AB Science Corporate Presentation Category: Investor RelationsBy Alexis BERNARD7 November 2019Tags: 2019 Partager cet article Share on LinkedInShare on LinkedIn Share on XShare on X Share on FacebookShare on Facebook Share on WhatsAppShare on WhatsApp Pin itShare on Pinterest Author: Alexis BERNARD Post navigationPreviousPrevious post:Positive top-line Phase 3 results for masitinib in severe asthmaNextNext post:Clarification regarding the article in the newspaper Les Echos related to the investigation by the French market authoritiesRelated PostsGovernance9 May 2018General Meeting preparatory documents6 May 2018Other information5 May 2018Frequently Asked Questions1 May 2018
